While Lykos Therapeutics’ MDMA therapy was rejected by the FDA, psychedelic therapy advocates remain optimistic about the ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

The post A Setback for MDMA-Assisted Psychotherapy appeared first on Reason.com. Autoblog chats to a hardcore Mustang fan and ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

As Psychiatric Times reported, this decision puts on hold what could have been a landmark approval for the treatment of PTSD with MDMA, also known as midomafetamine. Despite the setback, Lykos ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

Advocates are pushing for approval of psychedelic-assisted therapy from the FDA, seeking a means of therapy without fear of ...

A Boulder-based therapist characterized the decision as an enormous setback for those seeking treatment for PTSD.

MAPS shifts focus to state-level MDMA therapy legalization after FDA denial, advocating for ballot measures in states like Colorado, Oregon, and Massachusetts.

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock in August. The Food and Drug Administration (FDA) declined to approve a new drug application ...

More than 5 million Americans in treatment for depression could benefit from therapy with psilocybin -- the active ingredient ...